Browsing by Author Hatzimichael, E. C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 15 of 15
TitleAuthor(s)Issue date
Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patientsMakis, A. C.; Hatzimichael, E. C.; Mavridis, A.; Bourantas, K. L.24-Nov-2015
C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Stebbing, J.; Bourantas, K. L.24-Nov-2015
Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatmentMakis, A. C.; Hatzimichael, E. C.; Kolios, G.; Bourantas, K. L.24-Nov-2015
The genomics of new drugs in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Stebbing, J.24-Nov-2015
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromesVoulgari, P. V.; Hatzimichael, E. C.; Tsiara, S.; Tzallas, C.; Drosos, A. A.; Bourantas, K. L.24-Nov-2015
A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survivalChristou, L.; Hatzimichael, E. C.; Sotsiou-Candila, F.; Siamopoulos, K.; Bourantas, K. L.24-Nov-2015
Peri-operative use of recombinant human erythropoietin in Jehovah's WitnessesBourantas, K. L.; Xenakis, T. A.; Hatzimichael, E. C.; Kontogeorgakos, V.; Beris, A. E.24-Nov-2015
Prolonged interferon-alpha-2b treatment of hairy cell leukemia patientsBourantas, K. L.; Hatzimichael, E. C.; Makis, A. C.; Kapsali, E.; Tsiara, S.; Christou, L.; Seferiadis, K.24-Nov-2015
Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patientMakis, A. C.; Chaliasos, N.; Hatzimichael, E. C.; Bourantas, K. L.24-Nov-2015
The role of cytokines in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Bourantas, K. L.24-Nov-2015
Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disordersBourantas, K. L.; Hatzimichael, E. C.; Makis, A. C.; Chaidos, A.; Kapsali, E. D.; Tsiara, S.; Mavridis, A.24-Nov-2015
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patientsSfagos, C.; Makis, A. C.; Chaidos, A.; Hatzimichael, E. C.; Dalamaga, A.; Kosma, K.; Bourantas, K. L.24-Nov-2015
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseasesPanteli, K. E.; Hatzimichael, E. C.; Bouranta, P.; Katsaraki, A.; Seferiadis, K.; Stebbing, J.; Bourantas, K. L.24-Nov-2015
Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenstrom's macroglobulinemiaHatzimichael, E. C.; Christou, L.; Bai, M.; Kolios, G.; Kefala, L.; Bourantas, K. L.24-Nov-2015
Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosisMakis, A. C.; Galanakis, E.; Hatzimichael, E. C.; Papadopoulou, Z. L.; Siamopoulou, A.; Bourantas, K. L.24-Nov-2015